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Glycemic Variability, hypoglycemia and organ failure in 
the Glucontrol study 
 
High glycemic variability and hypoglycemia are both 
associated with increase in SOFA score, and thus increase in 
organ failure rate. 
Results 
Methods 
Fig. 1 : Evolution of mean SOFA score for patients 
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Introduction 
 
Organ failure is a common complication associated with increased mortality in Intensive Care Unit (ICU) patients. Increased 
mortality is also related to glycemic variability (GV) and hypoglycemia [1]. This research evaluates the influence of GV and severe 
hypoglycemia on organ failure rate. 
Patients:  
N=704 (Glucontrol study) 
Randomized  
• Intensive Insulin Therapy (IIT), blood glucose (BG) target: 4.4-6.1 mmol/L (N=350)  
• Conventional Insulin Therapy (CIT), BG target: 7.8-10.0 mmol/L (N=354) 
Matched for age, sex, diagnosis and severity of illness (APACHE II score) 
Daily assessment:  
Organ failure: SOFA score 





𝑁   
Hypoglycemic event: BG < 2,2 mmol/L 
GV and SOFA score:  
High GV patients on Day i 
Patients on Day i 
Low GV patients on Day i 
𝐺𝑉𝑝,𝑖 > median(𝐺𝑉𝑖) 𝐺𝑉𝑝,𝑖 > median(𝐺𝑉𝑖) 
Hypoglycemia and SOFA score:  
Hypoglycemic event? 
Patients 
Hypo patients No-hypo patients  
Yes No 
Comparison of daily SOFA scores (median, IQR, mean) for each group, on each day. 
Note: glycemic outcome are considered independently of glycemic target. 









































Fig. 2 : Evolution of mean SOFA score for patients 
with (red) and without (blue) hypoglycemic event 
 
Patients with high GV: higher 
SOFA score  
(p < 0,05 on Days 2-4) 
 
Patients with a hypoglycemic 
event: higher SOFA scores  
(p < 0,05 on Days 2-14) 
 
Results matched with those of 
other studies 
– – – High GV patients 
– – – Low GV patients 
– – – Hypo patients 
– – – No-hypo patients 
